Pancreatic Cancer Research

ResearcherOsaka Medical and Pharmaceutical UniversityActive in the last 2 years

Takeshi Ogura

Matched on ORCID iD 0000-0003-2916-6568; OpenAlex author ID A5020893636, A5086172496. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage. Co-author DOI 10.1111/den.70229↗
  2. Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE SIX STUDY. Co-author DOI 10.1111/jgh.16524↗
  3. Gastrojejunostomy versus endoscopic duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer: a propensity score… Co-author DOI 10.1007/s00464-022-09685-x↗
  4. Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter p… Co-author DOI 10.1007/s10147-022-02160-6↗
  5. Pancreatic ductal adenocarcinoma masquerading as a serous cystic tumor (with videos). Co-author DOI 10.4103/eus.eus_92_17↗
  6. Choledochoduodenal Fistula after the Placement of a Partially Covered Metal Stent for Unresectable Pancreatic Cancer. First author DOI 10.2169/internalmedicine.55.6060↗
  7. Duodenal stent placement for duodenal obstruction caused by pancreatic cancer associated with annular pancreas. Co-author DOI 10.1016/j.gie.2014.04.011↗
  8. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancrea… Co-author DOI 10.1007/s00535-012-0664-2↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mamoru Takenaka · 3 shared papers, 2022–2026 · strength 0.50
  2. Masayuki Kitano · 3 shared papers, 2022–2026 · strength 0.50
  3. Takashi Tamura · 2 shared papers, 2023–2026 · strength 0.35
  4. Ippei Matsumoto · 2 shared papers, 2023–2026 · strength 0.35
  5. Kazuhide Higuchi · 4 shared papers, 2013–2018 · strength 0.24
  6. Akiko Tsujimoto · 1 shared paper, 2026 · strength 0.20
  7. Koh Kitagawa · 1 shared paper, 2026 · strength 0.20
  8. Yuki Ishikawa‐Kakiya · 1 shared paper, 2026 · strength 0.20
  9. Tsukasa Ikeura · 1 shared paper, 2026 · strength 0.20
  10. Tomoya Emori · 1 shared paper, 2026 · strength 0.20
  11. Yoshihiro Nishikawa · 1 shared paper, 2026 · strength 0.20
  12. Tomoaki Matsumori · 1 shared paper, 2026 · strength 0.20
  13. Atsuhiro Masuda · 1 shared paper, 2026 · strength 0.20
  14. Takashi Ito · 1 shared paper, 2026 · strength 0.20
  15. Toshifumi Doi · 1 shared paper, 2026 · strength 0.20
  16. Takuo Yamai · 1 shared paper, 2026 · strength 0.20
  17. Minako Nagai · 1 shared paper, 2026 · strength 0.20
  18. Susumu Hijioka · 2 shared papers, 2013–2024 · strength 0.19
  19. Yusuke Ishida · 1 shared paper, 2024 · strength 0.16
  20. Yasuhito Tanaka · 1 shared paper, 2024 · strength 0.16
  21. Daiki Yamashige · 1 shared paper, 2024 · strength 0.16
  22. Hidetoshi Kitamura · 1 shared paper, 2024 · strength 0.16
  23. Masanari Sekine · 1 shared paper, 2024 · strength 0.16
  24. Dai Inoue · 1 shared paper, 2024 · strength 0.16
  25. Reiko Yamada · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.